文献速递血栓与止血

效应记忆CD4+ T细胞增多与儿童慢性免疫性血小板减少症相关

Increased effector memory CD4+ T cells are associated with chronic childhood immune thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2025-06-10

该研究在158例新诊断儿童免疫性血小板减少症(ITP)患儿中分析免疫表型,评估自发血小板恢复及对静脉注射免疫球蛋白的反应。研究发现效应记忆CD4+ T细胞在慢性ITP中年龄校正后升高1.4%(95%CI 0.4-2.4),其频率高于中位数与恢复可能性降低相关(年龄和治疗校正HR 0.55,95%CI 0.35-0.85),且分层分析显示其对儿童ITP恢复评分有额外预后价值。

要点

  • CD4+、CD8+、CD19+及自然杀伤细胞群均未预测慢性ITP发展或随访期间恢复。
  • 慢性ITP中效应记忆CD4+ T细胞年龄校正后升高1.4%(95%CI 0.4-2.4)。
  • 效应记忆CD4+ T细胞频率高于中位数与恢复可能性降低相关(HR 0.55,95%CI 0.35-0.85)。

核心结论

  • 整合素β1阳性效应记忆CD4+ T细胞增多与慢性ITP相关,并提高临床预测模型的预后价值。
  • T细胞表型分析可能对新诊断儿童ITP的预后和个体化治疗有价值。

研究设计与样本

  • 研究分析158例新诊断ITP患儿诊断时、治疗前的免疫特征,数据来自「Treatment With or Without IVIg for Kids with ITP」随机对照试验。
  • 随访1年评估自发血小板恢复和对静脉注射免疫球蛋白的反应。
  • 对6例患儿的外周血单个核细胞进行单细胞RNA测序。

主要发现

  • CD4+、CD8+、CD19+及自然杀伤细胞群均未预测慢性ITP发展或随访期间恢复。
  • 慢性ITP中效应记忆CD4+ T细胞年龄校正后升高1.4%(95%CI 0.4-2.4)。
  • 效应记忆CD4+ T细胞频率高于中位数与恢复可能性降低相关,年龄和治疗校正HR为0.55(95%CI 0.35-0.85)。
  • 按效应记忆CD4+ T细胞水平分层显示对儿童ITP恢复评分有额外预后价值。
  • 6例患儿单细胞RNA测序证实慢性ITP中效应记忆CD4+ T细胞扩增,其特征为ITGB1(整合素β1,CD29)高表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibody- and T-cell immune responses against platelet self-antigens are key features of childhood immune thrombocytopenia (ITP). Reliable diagnostic and prognostic immune markers remain underdeveloped and are not currently used in clinical practice. OBJECTIVES: To validate previously suggested biomarkers and identify novel predictors of chronic childhood ITP. METHODS: We analyzed immune profiles in 158 children with newly diagnosed ITP at the time of diagnosis prior to treatment ("Treatment With or Without IVIg for Kids with ITP" randomized controlled trial). Spontaneous platelet recovery and response to intravenous immunoglobulin were evaluated during 1 year. RESULTS: Neither CD4+, CD8+, CD19+, nor natural killer cell populations predicted the development of chronic ITP or recovery during follow-up. However, we observed a significant age-adjusted increase in effector memory CD4+ T cells by 1.4% (95% CI, 0.4-2.4) in chronic ITP. A frequency of effector memory CD4+ T cells above the median was associated with a reduced likelihood of recovery, with an age- and treatment-adjusted hazard ratio of 0.55 (95% CI, 0.35-0.85). Stratification by effector memory CD4+ T-cell levels demonstrated additional prognostic value over the Childhood ITP Recovery Score, a clinical prediction model. Single-cell RNA-sequencing of peripheral blood mononuclear cells of 6 children confirmed an expansion of effector memory CD4+ T cells in chronic ITP, characterized by high expression of ITGB1 (integrin β1, CD29). CONCLUSIONS: Increased integrin β1-positive effector memory CD4+ T cells are associated with chronic ITP and improve the prognostic value of a clinical prediction model. T-cell phenotyping could be valuable for prognosis and personalized treatment in newly diagnosed childhood ITP.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Schmidt DE, Heitink-Pollé KMJ, Nicolet BP, et al. Increased effector memory CD4+ T cells are associated with chronic childhood immune thrombocytopenia. J Thromb Haemost. 2025. PMID: 40505868. doi:10.1016/j.jtha.2025.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。